AusBiotech’s biotechnology-specific professional development program is running an express survey to see if it is meeting your professional development needs. [ + ]

The 15th International Conference on Systems Biology will be held in Melbourne in 2014. [ + ]

CSIRO and Cotton Seed Distributors (CSD) have announced a five-year, $35 million extension to their existing agreement to fund projects through the Cotton Breeding Australia joint venture. [ + ]

Allied Healthcare's (ASX:AHZ) tissue engineering division has implanted its CardioCel patch in heart valve reconstructions, during a phase I animal trial. [ + ]

Anteo Diagnostics (ASX:ADO) has signed a potentially lucrative licensing deal for its Mix&Go molecular glue with US-based eBiosciences. [ + ]

AusBiotech’s CEO, a number of its directors and 20 of its member CEOs and executives will tomorrow be hosted at Parliament House for this year’s CEO Forum addressing issues in innovation policy and programs. [ + ]

A salt-tolerant variety of durum wheat that outperforms other varieties by 25% on salty soils has been developed by CSIRO scientists using traditional crop breeding techniques. [ + ]

A new variety of salt tolerance durum wheat produced by Australian researchers could significant boost yields here and overseas and help farmers respond to climate change. [ + ]

A century old puzzle of how a clot-busting protein, plasminogen, is activated in the body has been solved, possibly leading to new treatments for bleeding disorders and some cancers. [ + ]

Human albumin manufactured by CSL has been quarantined by the Therapeutic Goods Administration due to fears it may be contaminated with ethylene glycol. [ + ]

The Australian Academy of Science and the Embassy of France today announced a new Fellowship program to help young Australian scientists work with cutting-edge French research institutions. [ + ]

CERN’s ALPHA collaboration has reported the first measurement of the antihydrogen spectrum. [ + ]

Researchers at Monash University have used X-ray beams created by the Australian Synchrotron (AS) to discover how enzymes work to dissolve blood clots and clean up damaged tissue in the body - a finding that could ultimately lead to a reduction in the number of heart disease-related deaths occurring each year as a result of blood clots. [ + ]

Osprey Medical, a US-headquartered medical device company developing products based on Australian research, plans to list on the ASX via a $20m IPO. [ + ]

AusBiotech is pleased to announce that the first edition for 2012 (March issue) of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a special medical technology edition. [ + ]